electroCore Announces Dr. Peter Staats to Keynote the Fifth Annual Bioelectronic Medicine Forum in New York
23 Março 2022 - 9:00AM
electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a
commercial-stage bioelectronic medicine company, today
announced its co-founder and Chief Medical Officer, Dr. Peter
Staats, will keynote the Fifth Annual Bioelectronic Medicine Forum
on April 5, 2022.
The event will take place in New York City and will cover a
range of technologies and indications for bioelectronic medicine,
including applications in cardiovascular medicine, inflammation,
gastrointestinal disorders, and many other clinical
specialties.
Other panelists and presenters at the 2022 event include Marom
Biksom, Professor of Biomedical Engineering at City College of New
York; Imran Eba, partner at Action Potential Venture Capital; and
Eric Van Gieson, Ph.D., Program Manager at DARPA Biological
Technologies Office; and prior keynote speakers include Murthy
Simhambhatla, the President and CEO of SetPoint Medical.
Dr. Staats is the former President of the North American
Neuromodulation Society, American Society of Interventional Pain
Physicians, New Jersey Society of Interventional Pain Physicians,
and the Southern Pain Society. He is currently President of the
World Institute of Pain and continues to serve as Chief Medical
Officer for National Spine and Pain Centers, the largest pain
practice in the United States, and electroCore, Inc.
About electroCore, Inc.electroCore, Inc. is a
commercial stage bioelectronic medicine company dedicated to
improving patient outcomes through its platform non-invasive vagus
nerve stimulation therapy initially focused on the treatment of
multiple conditions in neurology. The company’s current indications
are the preventative treatment of cluster headache and migraine and
acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
Investors:Rich CockrellCG
Capital404-736-3838ecor@cg.capital
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024